These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13986080)

  • 1. [Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    PRETOLANI E
    Gazz Int Med Chir; 1963 May; 67():1011-21. PubMed ID: 13986080
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
    CESARI L
    Gazz Int Med Chir; 1962 Sep; 66():1994-2004. PubMed ID: 14019763
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
    MIGHELI B; ANSELMINO A; BERT G; ANFOSSI F; BIANCO A; PUPITA F
    Clin Ter; 1963 Mar; 24():530-42. PubMed ID: 13935671
    [No Abstract]   [Full Text] [Related]  

  • 4. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
    PARON R; DA BROI GL
    Gazz Int Med Chir; 1962 Nov; 66():2496-521. PubMed ID: 13941569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary observations on the therapy of angina pectoris with a new synthetic drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    GUERRICCHIO G
    Minerva Cardioangiol; 1962 Nov; 10():766-71. PubMed ID: 13951123
    [No Abstract]   [Full Text] [Related]  

  • 7. [INVESTIGATION ON THE BEHAVIOR OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN) AGAINST THE ACTION OF NORADRENALINE].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():475-84. PubMed ID: 14103284
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESEARCH ON THE ANTIFIBRILLATORY ACTION OF 3,3-DIPHENYL-N-(ALPHA-METHYLPHENETHYL)-3-PROPYLAMINE (SEGONTIN)].
    LINDNER E
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():485-500. PubMed ID: 14103285
    [No Abstract]   [Full Text] [Related]  

  • 9. [3,3-Diphenyl-N-(alpha-methylphenethyl)-propylamine].
    URBINATI G
    Clin Ter; 1961 Aug; 21():178-86. PubMed ID: 13779294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
    DE FELICE D; ROSSETTO L
    Gazz Int Med Chir; 1962 Sep; 66():1976-84. PubMed ID: 14025758
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analogy of the effects of N-(1-methyl-2-phenylethyl)-1, 1-diphenyl-3-propylamine (Segontin) and reserpine on arterial pressure].
    SCHMITT H; SCHMITT H
    C R Seances Soc Biol Fil; 1962; 156():440-2. PubMed ID: 13908832
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE ACTION OF N-(2-PHENYL-1-METHYLETHYL)-1,1-DIPHENYL-3-PROPYLAMINE ON ANGINA OF EFFORT].
    BRONSTEIN J; GALEANO JC; GOLDSTEIN B; PITTALUGA E; STEINMAN J
    Dia Med; 1963 Nov; 35():1950-1. PubMed ID: 14099805
    [No Abstract]   [Full Text] [Related]  

  • 13. [3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amine (Segontin).
    MALTEZ JS
    J Med (Oporto); 1963 Jan; 50():189-202. PubMed ID: 13932641
    [No Abstract]   [Full Text] [Related]  

  • 14. [PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
    FRANZINI C; TURRI C; MONTEROSSO A
    Minerva Cardioangiol; 1964 Dec; 12():515-27. PubMed ID: 14269033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the behavior of the heart minute volume and further hemodynamic values under the effect of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
    PIPPIG L; SCHNEIDER KW; HOCHREIN H
    Med Klin; 1962 Aug; 57():1475-81. PubMed ID: 13943727
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
    MENCI S
    Gazz Int Med Chir; 1964 Jan; 68():98-109. PubMed ID: 14123796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on the subject of clinical experimentation of a new synthetic antianginal compound: N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
    MATANO F; ROMANO V
    Minerva Med; 1963 Apr; 54():1193-9. PubMed ID: 13933526
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new synthetic substance in the therapy of angina pectoris, N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
    BAROCELLI C
    Minerva Med; 1963 Apr; 54():1202-6. PubMed ID: 13969419
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
    TRILLA SANCHEZ E; BELLONCANEIRO JM; TORNER SOLER M
    Rev Esp Cardiol; 1963 Oct; 16():873-84. PubMed ID: 14117507
    [No Abstract]   [Full Text] [Related]  

  • 20. [METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
    ZOLI A; BRAT A; GIARDINA A
    Riv Crit Clin Med; 1963 Apr; 63():75-90. PubMed ID: 14277814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.